FDA penalize for delay or denial of inspectors

FDA Flexes New Muscle on Drug Supply chain- The FDA on Friday issued a draft guidance implementing penalties for manufacturers who delay inspections or deny access to inspectors, the agency announced at a day-long public meeting here on drug supply chains.

visit us at The Center for Medical Healing for more information.